Literature DB >> 16617256

The two-event model of transfusion-related acute lung injury.

Christopher C Silliman1.   

Abstract

The objective of this review is to present the two-event model of transfusion-related acute lung injury (TRALI), a life-threatening complication of transfusions that has been the most common cause of transfusion-related death over the past 2 yrs in the United States. The two-event model of TRALI, which is identical to the pathogenesis of the acute respiratory distress syndrome (ARDS), is reviewed and contrasted to antibody-mediated TRALI. Laboratory studies, both in vitro and in vivo, are discussed as well as human studies of TRALI. Methods to avoid patient exposure to blood components that may cause TRALI are also discussed.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16617256     DOI： 10.1097/01.CCM.0000214292.62276.8E

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


  60 in total

1.  Leukotriene b4 and its metabolites prime the neutrophil oxidase and induce proinflammatory activation of human pulmonary microvascular endothelial cells.

Authors:  John C Eun; Ernest E Moore; Anirban Banerjee; Marguerite R Kelher; Samina Y Khan; David J Elzi; Nathan J D McLaughlin; Christopher C Silliman
Journal:  Shock       Date:  2011-03       Impact factor: 3.454

2.  Swiss Haemovigilance Data and Implementation of Measures for the Prevention of Transfusion Associated Acute Lung Injury (TRALI).

Authors:  Markus Jutzi; Guy Levy; Behrouz Mansouri Taleghani
Journal:  Transfus Med Hemother       Date:  2008-03-17       Impact factor: 3.747

3.  Fresh red blood cell transfusion and short-term pulmonary, immunologic, and coagulation status: a randomized clinical trial.

Authors:  Daryl J Kor; Rahul Kashyap; Richard B Weiskopf; Gregory A Wilson; Camille M van Buskirk; Jeffrey L Winters; Michael Malinchoc; Rolf D Hubmayr; Ognjen Gajic
Journal:  Am J Respir Crit Care Med       Date:  2012-01-26       Impact factor: 21.405

4.  Red blood cell storage and transfusion-related immunomodulation.

Authors:  Rosemary L Sparrow
Journal:  Blood Transfus       Date:  2010-06       Impact factor: 3.443

Review 5.  Protocols for massive blood transfusion: when and why, and potential complications.

Authors:  E Guerado; A Medina; M I Mata; J M Galvan; M L Bertrand
Journal:  Eur J Trauma Emerg Surg       Date:  2015-12-09       Impact factor: 3.693

6.  Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantation.

Authors:  Alexander B Benson; James R Burton; Gregory L Austin; Scott W Biggins; Michael A Zimmerman; Igal Kam; Susan Mandell; Christopher C Silliman; Hugo Rosen; Marc Moss
Journal:  Liver Transpl       Date:  2011-02       Impact factor: 5.799

7.  Properties of stored red blood cells: understanding immune and vascular reactivity.

Authors:  Philip C Spinella; Rosemary L Sparrow; John R Hess; Philip J Norris
Journal:  Transfusion       Date:  2011-04       Impact factor: 3.157

8.  Determinants of transfusion decisions in a mixed medical-surgical intensive care unit: a prospective cohort study.

Authors:  Alexander P J Vlaar; Anne L In der Maur; Jan M Binnekade; Marcus J Schultz; Nicole P Juffermans
Journal:  Blood Transfus       Date:  2009-04       Impact factor: 3.443

9.  Recommendations from the Tuscan Transfusion System on the appropriate use of solvent/detergent-inactivated fresh-frozen plasma.

Authors:  Giancarlo Maria Liumbruno; Maria Laura Sodini; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2008-01       Impact factor: 3.443

10.  Mirasol Pathogen Reduction Technology treatment does not affect acute lung injury in a two-event in vivo model caused by stored blood components.

Authors:  C C Silliman; S Y Khan; J Bradley Ball; M R Kelher; S Marschner
Journal:  Vox Sang       Date:  2009-11-25       Impact factor: 2.144
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.